Mary Y. Chang

1.4k total citations
30 papers, 1.0k citations indexed

About

Mary Y. Chang is a scholar working on Cell Biology, Immunology and Molecular Biology. According to data from OpenAlex, Mary Y. Chang has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cell Biology, 14 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Mary Y. Chang's work include Proteoglycans and glycosaminoglycans research (15 papers), Immune Response and Inflammation (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mary Y. Chang is often cited by papers focused on Proteoglycans and glycosaminoglycans research (15 papers), Immune Response and Inflammation (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mary Y. Chang collaborates with scholars based in United States, Japan and United Kingdom. Mary Y. Chang's co-authors include Thomas N. Wight, Charles W. Frevert, Alan Chait, Inkyung Kang, Christina Tsoi, Christina K. Chan, Ingrid A. Harten, Stephen P. Evanko, Oliver M.T. Pearce and Susan Potter‐Perigo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Mary Y. Chang

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Y. Chang United States 19 418 352 287 251 197 30 1.0k
Madalina V. Nastase Germany 9 466 1.1× 288 0.8× 251 0.9× 166 0.7× 104 0.5× 12 1.1k
Kornélia Baghy Hungary 22 645 1.5× 353 1.0× 186 0.6× 277 1.1× 233 1.2× 54 1.3k
Josefin Ahnström United Kingdom 22 804 1.9× 226 0.6× 211 0.7× 166 0.7× 433 2.2× 53 1.8k
Shuhei Yoshida Japan 16 563 1.3× 294 0.8× 144 0.5× 196 0.8× 210 1.1× 77 1.4k
Helena Frey Germany 11 378 0.9× 297 0.8× 177 0.6× 142 0.6× 46 0.2× 12 769
Usman Yaqoob United States 19 717 1.7× 188 0.5× 171 0.6× 278 1.1× 156 0.8× 29 1.4k
O Cecconi United States 9 604 1.4× 290 0.8× 345 1.2× 167 0.7× 129 0.7× 11 1.4k
P. J. Quesenberry United States 19 608 1.5× 444 1.3× 355 1.2× 162 0.6× 103 0.5× 45 1.5k
Thorsten Sadowski Germany 17 399 1.0× 121 0.3× 166 0.6× 371 1.5× 113 0.6× 33 1.2k
Ge‐Liang Xu China 23 661 1.6× 106 0.3× 195 0.7× 354 1.4× 121 0.6× 62 1.3k

Countries citing papers authored by Mary Y. Chang

Since Specialization
Citations

This map shows the geographic impact of Mary Y. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Y. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Y. Chang more than expected).

Fields of papers citing papers by Mary Y. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Y. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Y. Chang. The network helps show where Mary Y. Chang may publish in the future.

Co-authorship network of co-authors of Mary Y. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Y. Chang. A scholar is included among the top collaborators of Mary Y. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Y. Chang. Mary Y. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reeves, Stephen R., Mary Y. Chang, Christina K. Chan, et al.. (2024). Inter-alpha-trypsin inhibitor (IαI) and hyaluronan modifications enhance the innate immune response to influenza virus in the lung. Matrix Biology. 126. 25–42. 8 indexed citations
2.
Chang, Mary Y., Christina K. Chan, Anne M. Manicone, et al.. (2024). Regulation of versican expression in macrophages is mediated by canonical type I interferon signaling via ISGF3. American Journal of Physiology-Cell Physiology. 327(5). C1274–C1288.
3.
Chang, Mary Y., et al.. (2023). Multicompartmental analysis of the murine pulmonary immune response by spectral flow cytometry. American Journal of Physiology-Lung Cellular and Molecular Physiology. 325(4). L518–L535. 7 indexed citations
4.
Chang, Mary Y., et al.. (2022). Defining the versican interactome in lung health and disease. American Journal of Physiology-Cell Physiology. 323(2). C249–C276. 13 indexed citations
5.
Wight, Thomas N., Inkyung Kang, Stephen P. Evanko, et al.. (2020). Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation. Frontiers in Immunology. 11. 512–512. 173 indexed citations
6.
Long, Matthew E., William E. Eddy, Mary Y. Chang, et al.. (2018). Matrix metalloproteinase 28 is regulated by TRIF- and type I IFN-dependent signaling in macrophages. Innate Immunity. 24(6). 357–365. 9 indexed citations
7.
Kang, Inkyung, Mary Y. Chang, Thomas N. Wight, & Charles W. Frevert. (2018). Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection. Journal of Histochemistry & Cytochemistry. 66(4). 241–259. 42 indexed citations
8.
Wu, Rong, Manoj Gandhi, Hanspaul S. Makkar, et al.. (2016). microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis. Modern Pathology. 29(5). 461–475. 38 indexed citations
9.
Kang, Inkyung, Ingrid A. Harten, Mary Y. Chang, et al.. (2016). Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation. Journal of Biological Chemistry. 292(1). 51–63. 51 indexed citations
10.
Snyder, Jessica M., Ida M. Washington, Timothy P. Birkland, Mary Y. Chang, & Charles W. Frevert. (2015). Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry. Journal of Histochemistry & Cytochemistry. 63(12). 952–967. 30 indexed citations
11.
Chang, Mary Y., Yoshinori Tanino, Veronika Vidová, et al.. (2014). A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biology. 34. 1–12. 64 indexed citations
12.
Chang, Mary Y., Yoshinori Tanino, Veronika Vidová, et al.. (2014). Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biology. 35. 162–173. 25 indexed citations
13.
Tanino, Yoshinori, Mary Y. Chang, Xintao Wang, et al.. (2012). Syndecan-4 Regulates Early Neutrophil Migration and Pulmonary Inflammation in Response to Lipopolysaccharide. American Journal of Respiratory Cell and Molecular Biology. 47(2). 196–202. 51 indexed citations
14.
Chang, Mary Y., Christina K. Chan, Kathleen R. Braun, et al.. (2012). Monocyte-to-Macrophage Differentiation. Journal of Biological Chemistry. 287(17). 14122–14135. 81 indexed citations
15.
Chiba, Tsuyoshi, Mary Y. Chang, Shari Wang, et al.. (2011). Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular Proteoglycans. Arteriosclerosis Thrombosis and Vascular Biology. 31(6). 1326–1332. 57 indexed citations
16.
Chang, Mary Y., et al.. (2005). Antioxidants Inhibit the Ability of Lysophosphatidylcholine to Regulate Proteoglycan Synthesis. Arteriosclerosis Thrombosis and Vascular Biology. 26(3). 494–500. 10 indexed citations
17.
Chang, Mary Y., Christina Tsoi, Thomas N. Wight, & Alan Chait. (2003). Lysophosphatidylcholine Regulates Synthesis of Biglycan and the Proteoglycan Form of Macrophage Colony Stimulating Factor. Arteriosclerosis Thrombosis and Vascular Biology. 23(5). 809–815. 31 indexed citations
18.
Chang, Mary Y., Susan Potter‐Perigo, Christina Tsoi, Alan Chait, & Thomas N. Wight. (2000). Oxidized Low Density Lipoproteins Regulate Synthesis of Monkey Aortic Smooth Muscle Cell Proteoglycans That Have Enhanced Native Low Density Lipoprotein Binding Properties. Journal of Biological Chemistry. 275(7). 4766–4773. 78 indexed citations
19.
Chang, Mary Y., Ann M. Lees, & Robert S. Lees. (1993). Low-density lipoprotein modification and arterial wall accumulation in a rabbit model of atherosclerosis. Biochemistry. 32(33). 8518–8524. 27 indexed citations
20.
Shih, Ing‐Lung, Robert S. Lees, Mary Y. Chang, & Andrew Lees. (1990). Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall.. Proceedings of the National Academy of Sciences. 87(4). 1436–1440. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026